Middle East and Africa Neurovascular Devices Market

Market Introduction

Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain. Neurovascular disorders lead to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.

Middle East and Africa Neurovascular Devices Strategic Insights

Strategic insights for the Middle East and Africa Neurovascular Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East and Africa Neurovascular Devices Report Scope

Middle East and Africa Neurovascular Devices Regional Insights

The geographic scope of the Middle East and Africa Neurovascular Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Middle East and Africa neurovascular devices market is expected to reach US$ 144.08 Mn in 2027 from US$ 119.85 Mn in 2019. The market is estimated to grow with a CAGR of 2.4% from 2020-2027.  Key factors that are driving growth of Middle East and Africa Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.

Key Market Segments

The Middle East and Africa neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period.

The Middle East and Africa neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period.

Based on end user, the Middle East and Africa neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Middle East and Africa neurovascular devices market included in the report are Neurology Association of South Africa (NASA); World Bank; World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.

Reasons to buy the report

• To understand the Middle East and Africa Neurovascular devices market scope and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa neurovascular devices market.
• Efficiently plan M&A and partnership deals in Middle East and Africa neurovascular devices market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa neurovascular devices market.
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East and Africa.

Middle East and Africa North America Neurovascular Devices market –

By Product

• Neurothrombectomy Devices
  • Clot Retrieval Devices
  • Suction & Aspiration Devices
  • Snares
• Aneurysm Coiling & Embolization Devices
  • Embolic Coils
    • Bare Detachable Coils
    • Coated Detachable Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
• Cerebral Balloon Angioplasty & Stenting Systems
  • Carotid Artery Stents
  • Embolic Protection Systems
    • Balloon Occlusion Devices
    • Distal Fillers
• Support Devices
  • Microcatheters
  • Microguidewires

By Application

• Cerebral Aneurysms
• Arteriovenous Malformation & Fistulas
• Other Applications

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics

By Country

• • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

• Medtronic plc
• Johnson and Johnson, Inc (DePuy Synthes)
• Penumbra, Inc
• Terumo Corporation
• Acandis GmbH & Co. KG